AAAAAA
Results:
1-10
|
Results: 10
Authors:
Nap, M
van Wel, T
Andres, C
Bellanger, L
Bodenmuller, H
Bonfrer, H
Brundell, J
Einarsson, R
Erlandsson, A
Johansson, A
Leca, JF
Meier, T
Seguin, P
Sjodin, A
Stigbrand, T
Sundstrom, BE
van Dalen, A
Wiebelhaus, E
Wiklund, B
Hilgers, J
Citation: M. Nap et al., Immunohistochemical profiles of 30 monoclonal antibodies against cytokeratins 8, 18 and 19 - Second report of the TD5 workshop, TUMOR BIOL, 22(1), 2001, pp. 4-10
Authors:
Einarsson, R
Citation: R. Einarsson, Cytokeratins as tumor markers - Molecular and clinical data with focus on TPS, J TUMOR M, 15(3), 2000, pp. 163-169
Authors:
Lindman, H
Jansson, T
Arnberg, H
Bergh, J
Einarsson, R
Citation: H. Lindman et al., Serum markers TPS, TPA and CA 15-3 as monitors of chemotherapy in patientswith metastatic breast cancer, J TUMOR M, 15(3), 2000, pp. 177-186
Authors:
van Dalen, A
Einarsson, R
Citation: A. Van Dalen et R. Einarsson, Cytokeratin markers TPS, TPA and CYFRA in epithelial ovarian cancer, J TUMOR M, 15(3), 2000, pp. 187-194
Authors:
Einarsson, R
Lindman, H
Bergh, J
Citation: R. Einarsson et al., Use of TPS and CA 15-3 assays for monitoring chemotherapy in metastatic breast cancer patients, ANTICANC R, 20(6D), 2000, pp. 5089-5093
Authors:
Van Dalen, A
Favier, J
Baumgartner, L
Hasholzner, U
De Bruijn, H
Dobbler, D
Dombi, VH
Fink, D
Giai, M
Mcging, P
Harlozinska, A
Kainz, C
Markowska, J
Molina, R
Sturgeon, C
Bowman, A
Einarsson, R
Citation: A. Van Dalen et al., Serum levels of CA 125 and TPS during treatment of ovarian cancer, ANTICANC R, 20(6D), 2000, pp. 5107-5108
Authors:
van Dalen, A
Favier, J
Burges, A
Hasholzner, U
de Bruijn, HWA
Dobler-Girdziunaite, D
Dombi, VH
Fink, D
Giai, M
McGing, P
Harlozinska, A
Kainz, C
Markowska, J
Molina, R
Sturgeon, C
Bowman, A
Einarsson, R
Citation: A. Van Dalen et al., Prognostic significance of CA 125 and TPS levels after 3 chemotherapy courses in ovarian cancer patients, GYNECOL ONC, 79(3), 2000, pp. 444-450
Authors:
Slesak, B
Harlozinska-Szmyrka, A
Knast, W
Sedlaczek, P
van Dalen, A
Einarsson, R
Citation: B. Slesak et al., Tissue polypeptide specific antigen (TPS), a marker for differentiation between pancreatic carcinoma and chronic pancreatitis - A comparative study with CA 19-9, CANCER, 89(1), 2000, pp. 83-88
Authors:
Van Dalen, A
Favier, J
Baumgartner, L
Hasholzner, U
De Bruijn, H
Dobbler, D
Dombi, VH
Fink, D
Giai, M
McGing, P
Harlozinska, A
Kainz, C
Markowska, J
Molina, R
Sturgeon, C
Einarsson, R
Citation: A. Van Dalen et al., Prognostic significance of CA 125 and TPS levels after chemotherapy in ovarian cancer patients, ANTICANC R, 19(4A), 1999, pp. 2523-2526
Authors:
Einarsson, R
Lei, JD
Ullrich, A
van Dalen, A
Citation: R. Einarsson et al., Performance characteristics of IMMULITE (R) TPS (TM): A comparison with TPS (TM) IRMA, ANTICANC R, 19(4A), 1999, pp. 2743-2747
Risultati:
1-10
|